Clinical Trial Update: Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 1/2 study evaluating cyclosporine dose reduction and elimination in Chinese kidney transplant recipients has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Transplant | Phase 1, Phase 2 | Status: COMPLETED